Qatar Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping
Conditions:   Blood Disease;   Blood Transfusion, Autologous;   Blood Doping;   Blood Transfusion, Homologous Interventions:   Biological: Homologous Blood Transfusion;   Biological: Autologous Blood Transfusion Sponsors:   Hamad Medical Corporation;   World Anti-doping Agency;   Anti-Doping Lab Qatar;   Sidra Medical and Research Center;   Laboratorio Antidoping FMSI Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2018 Category: Research Source Type: clinical trials